David Arranz Solís

Title: David Arranz Solís: Innovator in Vaccine Composition

Introduction

David Arranz Solís is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of vaccine development, particularly through his innovative protein compositions. His work aims to enhance the effectiveness of treatments for infections caused by various pathogens.

Latest Patents

David Arranz Solís holds a patent for a vaccine composition. The invention relates to new protein compositions, methods for producing these compositions, and pharmaceutical formulations that include them. Specifically, the patent describes a protein composition that contains specified proteins in an amount at least about two times higher than their presence in the whole tachyzoite, as determined by quantitative label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS). This advancement has the potential to improve therapeutic strategies against infectious diseases.

Career Highlights

David is affiliated with the Universidad Complutense de Madrid, where he conducts research and develops innovative solutions in the field of immunology. His academic background and research experience have positioned him as a key figure in vaccine research.

Collaborations

He has collaborated with esteemed colleagues such as Javier Regidor Cerrillo and Esther Collantes Fernández. These partnerships have fostered a collaborative environment that enhances the research output and innovation in vaccine development.

Conclusion

David Arranz Solís is a pioneering inventor whose work in vaccine composition is paving the way for new treatments against infectious diseases. His contributions to the field are invaluable and reflect his commitment to advancing medical science.